Cargando…

Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC

OBJECTIVE: The purpose of this study was to evaluate different characteristics of COPD patients according to phenotypes and GOLD guidelines.according to GesEPOC phenotypes and GOLD 2011 ABCD guidelines and pharmacological treatment agreement. DESIGN: Cross-sectional survey. LOCATION: COPD patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: García García, Silvia, Carazo Fernández, Luis, Juan García, Javier, Naveiro Rilo, José Cesáreo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876058/
https://www.ncbi.nlm.nih.gov/pubmed/28292581
http://dx.doi.org/10.1016/j.aprim.2017.01.002
_version_ 1783473145592676352
author García García, Silvia
Carazo Fernández, Luis
Juan García, Javier
Naveiro Rilo, José Cesáreo
author_facet García García, Silvia
Carazo Fernández, Luis
Juan García, Javier
Naveiro Rilo, José Cesáreo
author_sort García García, Silvia
collection PubMed
description OBJECTIVE: The purpose of this study was to evaluate different characteristics of COPD patients according to phenotypes and GOLD guidelines.according to GesEPOC phenotypes and GOLD 2011 ABCD guidelines and pharmacological treatment agreement. DESIGN: Cross-sectional survey. LOCATION: COPD patients aged 40-85 from León were randomly selected from Primary Care database, MEDORA. PARTICIPANTS: 5222 eligible COPD patients were collected from MEDORA database. We calculated a sample size of 734 patients and finally studied 577 of them. MAIN MEASUREMENTS: Patientś clinical, functional and health related quality of life information were collected. Spirometry and postbroncodilator test were performed. RESULTS: A total of 577 patients were included in this study. 28.7% of them did not have a spirometry recorded in their files. 123 patients had a normal or non-obstructive spirometry pattern, so they were excluded from a COPD diagnostic. With regard to treatments, there was an overprescribing of inhaled steroids in patients from GOLD A and B groups, and also in patients with the called exacerbator phenotype (GesEPOC). CONCLUSION: Although there have been several published guidelines, management of COPD patients in real life should be improved.
format Online
Article
Text
id pubmed-6876058
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68760582019-11-26 Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC García García, Silvia Carazo Fernández, Luis Juan García, Javier Naveiro Rilo, José Cesáreo Aten Primaria Originales OBJECTIVE: The purpose of this study was to evaluate different characteristics of COPD patients according to phenotypes and GOLD guidelines.according to GesEPOC phenotypes and GOLD 2011 ABCD guidelines and pharmacological treatment agreement. DESIGN: Cross-sectional survey. LOCATION: COPD patients aged 40-85 from León were randomly selected from Primary Care database, MEDORA. PARTICIPANTS: 5222 eligible COPD patients were collected from MEDORA database. We calculated a sample size of 734 patients and finally studied 577 of them. MAIN MEASUREMENTS: Patientś clinical, functional and health related quality of life information were collected. Spirometry and postbroncodilator test were performed. RESULTS: A total of 577 patients were included in this study. 28.7% of them did not have a spirometry recorded in their files. 123 patients had a normal or non-obstructive spirometry pattern, so they were excluded from a COPD diagnostic. With regard to treatments, there was an overprescribing of inhaled steroids in patients from GOLD A and B groups, and also in patients with the called exacerbator phenotype (GesEPOC). CONCLUSION: Although there have been several published guidelines, management of COPD patients in real life should be improved. Elsevier 2017-12 2017-03-11 /pmc/articles/PMC6876058/ /pubmed/28292581 http://dx.doi.org/10.1016/j.aprim.2017.01.002 Text en © 2017 Elsevier España, S.L.U. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Originales
García García, Silvia
Carazo Fernández, Luis
Juan García, Javier
Naveiro Rilo, José Cesáreo
Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC
title Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC
title_full Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC
title_fullStr Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC
title_full_unstemmed Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC
title_short Enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. Estudio LEONPOC
title_sort enfermedad pulmonar obstructiva crónica: los pacientes en la vida real. estudio leonpoc
topic Originales
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876058/
https://www.ncbi.nlm.nih.gov/pubmed/28292581
http://dx.doi.org/10.1016/j.aprim.2017.01.002
work_keys_str_mv AT garciagarciasilvia enfermedadpulmonarobstructivacronicalospacientesenlavidarealestudioleonpoc
AT carazofernandezluis enfermedadpulmonarobstructivacronicalospacientesenlavidarealestudioleonpoc
AT juangarciajavier enfermedadpulmonarobstructivacronicalospacientesenlavidarealestudioleonpoc
AT naveirorilojosecesareo enfermedadpulmonarobstructivacronicalospacientesenlavidarealestudioleonpoc